Literature DB >> 6088017

Histologic grading of adenoid cystic carcinoma of the salivary glands.

P A Szanto, M A Luna, M E Tortoledo, R A White.   

Abstract

Seventy-nine patients with adenoid cystic carcinoma arising in salivary glands were studied to determine whether a correlation existed between the morphologic features of the tumor and the prognosis. Three histologic grades were established: Grade I, tumors with tubular and cribriform areas but without solid components; Grade II, cribriform tumors that were either pure or mixed with less than 30% of solid areas; and Grade III, tumors with a predominantly solid pattern. Cumulative survival rates at 15 years were 39%, 26%, and 5%, for Grades I, II, and III, respectively. Grade III tumors were larger, recurred frequently, and killed the patients within 4 years. Grade I lesions were smaller, were amenable to complete surgical excision, and had a protracted clinical course. Grade II tumors lay between the other two forms both clinically and pathologically. Other important prognostic features of the adenoid cystic carcinoma were its primary site, its presence or absence at surgical margins, and the anatomic structures it involved.

Entities:  

Mesh:

Year:  1984        PMID: 6088017     DOI: 10.1002/1097-0142(19840915)54:6<1062::aid-cncr2820540622>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  88 in total

Review 1.  Troublesome tumours 2: borderline tumours of salivary glands.

Authors:  J W Eveson
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

2.  SOX10 and GATA3 in Adenoid Cystic Carcinoma and Polymorphous Adenocarcinoma.

Authors:  Brian D Adkins; Ariana Geromes; Lily Y Zhang; Rebecca Chernock; Katherine Kimmelshue; James Lewis; Kim Ely
Journal:  Head Neck Pathol       Date:  2019-06-20

3.  Predictors of Outcome in Adenoid Cystic Carcinoma of Salivary Glands: A Clinicopathologic Study With Correlation Between MYB Fusion and Protein Expression.

Authors:  Bin Xu; Esther Drill; Allen Ho; Alan Ho; Lara Dunn; Carlos Nicolas Prieto-Granada; Timothy Chan; Ian Ganly; Ronald Ghossein; Nora Katabi
Journal:  Am J Surg Pathol       Date:  2017-10       Impact factor: 6.394

4.  Upregulation of lncRNA ADAMTS9-AS2 Promotes Salivary Adenoid Cystic Carcinoma Metastasis via PI3K/Akt and MEK/Erk Signaling.

Authors:  Shule Xie; Xin Yu; Yingru Li; Hanyu Ma; Song Fan; Weixiong Chen; Guokai Pan; Weiwei Wang; Hanqing Zhang; Jinsong Li; Zhaoyu Lin
Journal:  Mol Ther       Date:  2018-08-24       Impact factor: 11.454

5.  An immunohistochemical study of adenoid cystic carcinoma of the external auditory canal.

Authors:  K Ito; T Ito; M Tsukuda; M Kanisawa
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

6.  Oropharyngeal adenoid cystic carcinoma invading the mandibular bone through the mandibular foramen.

Authors:  Yohei Takeshita; Shunsuke Okada; Miki Hisatomi; Hidenobu Matsuzaki; Hotaka Kawai; Yohei Noda; Jun Murakami; Mariko Fujita; Hitoshi Nagatsuka; Yoshinobu Yanagi; Junichi Asaumi
Journal:  Oral Radiol       Date:  2018-11-15       Impact factor: 1.852

7.  A case of sublingual adenoid cystic carcinoma involving the mandible presenting as a "skip lesion".

Authors:  Mariko Fujita; Yoshinobu Yanagi; Arthur R G Cortes; Emiko Saito Arita; Tomoo Onoda; Hitoshi Nagatsuka; Jun-Ichi Asaumi
Journal:  Oral Radiol       Date:  2017-11-27       Impact factor: 1.852

Review 8.  An update on grading of salivary gland carcinomas.

Authors:  Raja R Seethala
Journal:  Head Neck Pathol       Date:  2009-02-25

9.  Adenoid cystic carcinoma ex pleomorphic adenoma of the parotid gland.

Authors:  Fumio Ide; Kenji Mishima; Hiroyuki Yamada; Ichiro Saito
Journal:  Head Neck Pathol       Date:  2009-02-28

10.  High grade transformation in adenoid cystic carcinoma of the parotid: report of a case with cytologic, histologic and immunohistochemical study.

Authors:  Kiran Preet Malhotra; Vinita Agrawal; Rakesh Pandey
Journal:  Head Neck Pathol       Date:  2009-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.